In post-mortem tissue from multiple sclerosis patients, immunohistochemical analysis of multiple sclerosis lesions highlighted increased expression and co-localisation of CLU with complement components C1q, C3b, C4d and MAC, compared to healthy controls [69]. This evidence concerns the gene C3 and multiple sclerosis.